Pharma Exclusives Pressreleases
Icosagen Completes €45 Million Expansion, Bringing Therapeutic Protein Discovery, Development and GMP Manufacturing Together Under One Roof
Tuesday, June 30, 2026Estoniabased biotechnology company Icosagen has completed a major strategic expansion to strengthen its integrated biologics development and manufacturing capabilities at a single site creating a seamless pathway
Shibuya Highlights Hydrogen Peroxide Vapor Decontamination System for Advanced Aseptic Control
Monday, June 29, 2026Shibuya Corporation a global leader in precision engineering and advanced automation has developed and refined its Hydrogen Peroxide Vapor Decontamination System HPVD over more than two decades to support advanced
Moderna Science Day Highlights Expanding Potential of mRNA Platform
Thursday, June 25, 2026Moderna Inc NASDAQMRNA today announced research and early development updates at its Science Day event
Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline
Friday, June 05, 2026Gilead Sciences Inc Nasdaq GILD and Lakefront Biotherapeutics NV Euronext Nasdaq LKFT today announced the successful completion of the previously announced acquisition
Biogen’s Salanersen Receives FDA Breakthrough Therapy Designation for Spinal Muscular Atrophy
Thursday, June 04, 2026Biogen Inc Nasdaq BIIB announced today that the US Food and Drug Administration FDA has granted salanersen Breakthrough Therapy Designation for the treatment of spinal muscular atrophy SMA Breakthrough
Moderna Announces Initiation of Phase 3 Study of Investigational mRNA Pandemic Influenza Vaccine Candidate
Wednesday, April 22, 2026Moderna Inc today announced that the first participants in the US and UK have been dosed in a Phase study of the Companys investigational mRNAbased H pandemic influenza vaccine candidate mRNA
Crown Bioscience and Turbine Partner to Connect AI-Driven Prediction with Organoid Validation in Translational Oncology
Tuesday, April 21, 2026Crown Bioscience a global contract research organization CRO and a JSR Life Sciences company today announced a strategic partnership with Turbine a leading virtual biology company to advance translational oncology
Biogen Enters into Agreement with TJ Biopharma for Felzartamab Assets in the Greater China Region
Monday, April 20, 2026Biogen Inc Nasdaq BIIB and TJ Biopharma TJ Bio today announced that the companies have entered into a definitive agreement under which Biogen has agreed to acquire TJ Bios exclusive rights
Thermo Fisher Scientific Launches Applied Biosystems™ PowerFlex™ Thermal Cycler to Advance PCR Flexibility and Productivity
Thursday, April 16, 2026Thermo Fisher Scientific Inc the world leader in serving science today announced the Applied Biosystems PowerFlex Thermal Cycler a nextgeneration polymerase chain reaction PCR instrument designed
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Tuesday, March 31, 2026Eli Lilly and Company and Centessa Pharmaceuticals plc Nasdaq CNTA a clinicalstage company developing a new class of medicines for the treatment of excessive daytime sleepiness and other neurological conditions
